(IBIB) iShares Trust - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • • Target Maturity

IBIB: Short-Term, Government, Treasury, U.S., Bond, Debt, Securities

The iShares Trust (IBIB) is an exchange-traded fund (ETF) designed to track the performance of inflation-protected U.S. Treasury obligations, known as Treasury Inflation-Protected Securities (TIPS). The fund focuses on TIPS with maturities between January 1, 2025, and October 15, 2025. By concentrating on a specific maturity range, the ETF provides exposure to a targeted segment of the TIPS market, allowing investors to manage interest rate risk and inflation sensitivity more precisely. The fund invests at least 80% of its assets in the underlying indexs component securities, ensuring high alignment with the indexs performance. TIPS are particularly attractive during periods of rising inflation, as their principal value adjusts semi-annually to reflect changes in the Consumer Price Index (CPI), offering a hedge against inflation erosion.

IBIB is categorized as a target maturity ETF, meaning it is designed to hold securities until they reach a specific maturity date. This structure allows investors to anticipate the funds behavior as it approaches maturity, with the portfolio gradually shifting toward shorter-duration securities. The funds average volume over the past 20 days is 8,451 shares, indicating moderate trading activity. Its last price of $25.57 reflects current market valuation, with short-term technical indicators showing a slightly bullish signal, as the 20-day SMA ($25.52) is marginally below the current price. The 50-day SMA ($25.42) and 200-day SMA ($24.98) suggest a gradual upward trend over the past year. The ATR of 0.02 highlights extremely low volatility, consistent with the nature of TIPS and short-duration government securities. The funds assets under management (AUM) of $29.35 million are relatively modest, indicating a niche product primarily targeted at investors seeking specific maturity exposure within the TIPS market.

Over the next three months, IBIB is expected to exhibit the following trends:

  • Price Range: $25.40 to $25.80, reflecting minimal volatility as indicated by the ATR of 0.02.
  • AUM is projected to remain stable or see a slight increase, supported by consistent demand for short-duration TIPS.
  • The 20-day SMA is likely to hover around $25.50, maintaining alignment with the current price level.

Additional Sources for IBIB ETF

IBIB ETF Overview

Market Cap in USD 29m
Category Target Maturity
TER 0.10%
IPO / Inception 2023-09-13

IBIB ETF Ratings

Growth 5y 32.3%
Fundamental -
Dividend 61.6%
Rel. Strength Industry -2.39
Analysts -
Fair Price Momentum 25.46 USD
Fair Price DCF -

IBIB Dividends

Dividend Yield 12m 5.02%
Yield on Cost 5y 5.37%
Annual Growth 5y 121.77%
Payout Consistency 100.0%

IBIB Growth Ratios

Growth Correlation 3m 99.7%
Growth Correlation 12m 99.9%
Growth Correlation 5y 99.9%
CAGR 5y 5.79%
CAGR/Max DD 5y 0.00
Sharpe Ratio 12m 1.02
Alpha 1.42
Beta 0.01
Volatility 0.87%
Current Volume 5.1k
Average Volume 20d 7.4k
What is the price of IBIB stocks?
As of March 14, 2025, the stock is trading at USD 25.59 with a total of 5,145 shares traded.
Over the past week, the price has changed by +0.12%, over one month by +0.35%, over three months by +1.38% and over the past year by +5.66%.
Is iShares Trust a good stock to buy?
Neither. Based on ValueRay Analyses, iShares Trust is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 32.32 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of IBIB as of March 2025 is 25.46. This means that IBIB is currently overvalued and has a potential downside of -0.51%.
Is IBIB a buy, sell or hold?
iShares Trust has no consensus analysts rating.
What are the forecast for IBIB stock price target?
According to ValueRays Forecast Model, IBIB iShares Trust will be worth about 27.5 in March 2026. The stock is currently trading at 25.59. This means that the stock has a potential upside of +7.46%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 27.5 7.5%